Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
23 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-23/emv-capital-acquires-antibiotic-assets-from-destiny-pharma
15 Jul 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/destiny-goes-private-stay-afloat-after-no-partner-found-anti-infection-drug
25 Apr 2024
// James Waldron FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/destiny-calls-time-sporegen-covid-collab-while-santhera-hands-lonodelestat-back-spexis
02 May 2023
// PHARMIWEB
https://www.pharmiweb.com/press-release/2023-05-02/destiny-pharma-and-sporegen-announce-update-from-research-collaboration-under-innovate-uk-grant-award-to-develop-a-biotherapeutic-treatment-spor-cov-for-covid-19-and-influenza
27 Feb 2023
// Paul Schloesser ENDPTS
https://endpts.com/uk-biotech-hands-off-mid-stage-c-difficile-drug-in-up-to-570m-deal/
24 Feb 2023
// Annalee Armstrong FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/destiny-seals-c-diff-therapys-phase-3-fate-sebela
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE